注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
TransMedics Group Inc是一家商业阶段的医疗技术公司。该公司专注于为多种疾病状态的终末期器官衰竭患者开发器官移植疗法。该公司设计和开发了器官护理系统(OCS),这是一种便携式器官灌注、优化和监测系统,利用其定制技术复制人体外供体器官的近生理条件。该公司设计了OCS技术平台,为供体器官灌注温暖、含氧、营养丰富的血液,同时保持器官处于活的、功能良好的状态。该公司已开发出三种OCS产品,分别用于肺、心脏和肝移植。该公司的产品包括OCS肺、OCS心和OCS肝。该公司的OCS产品由为每个器官定制的三个组件组成,包括OCS控制台,OCS灌注集和OCS解决方案。该公司还在为包括肾脏在内的其他器官开发OCS产品。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
David Weill | 57 | 2019 | Independent Director |
Stephanie S. Lovell | 61 | 2021 | Independent Director |
James R. Tobin | 76 | 2011 | Independent Chairman |
Waleed H. Hassanein | 55 | 1998 | Founder, President, CEO & Director |
Scott D. Solomon | - | - | Member of Advisory Board |
Bruce R. Rosengard | - | - | Member of Advisory Board |
Gayle Winters | - | - | Member of Advisory Board |
Robert L. Kormos | - | - | Member of Advisory Board |
Edward Zavala | - | - | Member of Advisory Board |
Thomas J. Gunderson | 72 | 2016 | Independent Director |
Edward M. Basile | 75 | 2016 | Independent Director |
Edwin M. Kania | 66 | 2003 | Independent Director |
Merilee Raines | 68 | 2021 | Independent Director |
José Núñez | - | - | Member of Advisory Board |
Ryszard T. Smolenski | - | - | Member of Advisory Board |
Valluvan Jeevanandam | - | - | Member of Advisory Board |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核